Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 811 results for "csl"

CSL-Novartis deal includes US cell-based flu vaccine plant
Centre For Infectious Disease Research and Policy

Novartis Sells Influenza Vaccine Division to CSL Limited

Novartis has sold its influenza vaccine business to Australian drugmaker CSL Limited for $275 million, the latest effort by Novartis to shift away from vaccines and focus on other types of products. The deal follows Novartis decision in April ... FDA News, 1 hour ago
CSL to Acquire Novartis\\' Flu Vax Business\\n Contract Pharma, 3 days ago
[x]  

102 images for csl

BioSpace, 9 hours ago
Otago Daily Times, 1 day ago
Auto Evolution, 4 days ago
BusinessWeek, 4 days ago
Sports Car Digest, 1 day ago
Sports Car Digest, 1 day ago
Philly.com, 3 days ago
TheBull.com.au, 4 days ago
BusinessWeek, 4 days ago
WA Today, 4 days ago
Telecom Lead

ZTE supports CSL Mobile to launch VoLTE services in Hong Kong

ZTE Corporation, a provider of telecommunications equipment and network solutions, has announced that it will support CSL Mobile Limited to launch VoLTE, or voice over LTE, services in Hong Kong. ZTE's VoLTE solution, a fully end-to-end 4G LTE ...
 Individual.com2 days ago ZTE's VoLTE Solution Helps CSL Bring Superior 4G Voice Service to Hong Kong  TMC Net3 days ago ZTE powers CSL Mobile VoLTE services in Hong Kong  Telecom Lead1 week ago ZTE powers CSL's VoLTE services offering in Hong Kong  Telecompaper1 week ago
[x]  
Melbourne Age

CSL's $1 billion flu shot

CSL says it will have a $1 billion influenza vaccine business within five years after the biotechnology company said it would pay $US275 million ($313.5 million) for Novartis' loss-making division. The unit will be combined with the $36 billion ...
 Melbourne Age4 days ago Deal makes CSL flu number two  WA Today5 days ago Novartis buy makes CSL flu giant  Melbourne Age5 days ago $US275m Novartis buy makes CSL flu giant  Inverell Times5 days ago
[x]  

CSL becomes number two flu vaccines firm

CSL expects its $US275 million ($A297.54 million) acquisition of Novartis's global influenza vaccine business will help it develop a more effective defence against flu. The blood plasma products and vaccines supplier announced on Monday that it had ...
 WA Today4 days ago CSL to pay $US275m for vaccine business  Sydney Morning Herald5 days ago
[x]  
Comtex SmarTrend

Top 3 Companies in the Industrial Conglomerates Industry With the Highest Future Earnings Growth (TYC, CSL, SXI)

(Financial News Network On) Below are the three companies in the Industrial Conglomerates industry with the highest future earnings growth. The growth of earnings per share (next fiscal year estimated vs. current fiscal year estimated) is important ...
 Individual.com1 day ago Top 5 Companies in the Industrial Conglomerates Industry with the Best Relative Performance (MMM, TYC, PHG, CSL, GE)  Individual.com4 days ago 3M is Among the Companies in the Industrial Conglomerates Industry With the Highest Free Cash Flow Per Share (MMM, CSL, DHR)  Individual.com3 days ago Shares of 3M Rank the Highest in Terms of Relative Performance in the Industrial Conglomerates Industry (MMM, TYC, DHR, CSL, PHG)  Comtex SmarTrend1 week ago
Ferret.com.au

CSL looks to develop treatment for Ebola

Melbourne-based biotech manufacturer CSL is working to develop "hyper immune" blood plasma products to fight the Ebola virus. AAP reports that the company is working with the World Health Organisation (WHO) and the Bill and Melinda Gates ...
 Ferret.com.au4 days ago

CSL predicts healthy prognosis for $US275m flu division

closed $A0.62 higher at $A76.28. CEO Paul Perreault unveiled a deal to purchase the influenza vaccines arm of global pharmaceutical group Novartis for $US275m ($A313.5m). Gordon Naylor, the CFO of CSL, said the combined business would be the ...
 Individual.com4 days ago

CSL flu buy not to be sneezed at

Paul Perreault, CEO of Australian-listed biotechnology company CSL, has announced the purchase for $US275m ($A312.2m) of the influenza vaccines arm of global pharmaceutical group Novartis. CSL CFO Gordon Naylor notes that the combined entity will ...
 Individual.com4 days ago
BusinessWeek

Australia's CSL Wants to Make Your Flu Shots

Even as Americans worry about Ebola, another virus with a long and deadly history is about to hit the U.S. Flu season is approaching. Every year, there are between three to five million severe influenza cases around the world, with up to half a ...
 BusinessWeek4 days ago

Potential Carlisle (CSL) Trade Has 2.74% Downside Protection

Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with Carlisle Cos Inc (http://www.marketintelligencecenter.com/symbol/CSL"CSL) that should provide a 2% return in just 54 days. Sell one Dec. '14 ...
 Individual.com4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less